Author: Keith Ashcroft

Transplant Immunosuppression: The Tacrolimus, Mycophenolate, and Steroids Protocol

Keith Ashcroft
|
March 29
|
10

A comprehensive guide to the standard triple-therapy regimen for kidney transplants, covering Tacrolimus, Mycophenolate, and Steroids, including side effects, monitoring, and long-term outlook.

Metabolic Syndrome: The Cluster of Heart Disease Risk Factors You Can't Ignore

Keith Ashcroft
|
March 23
|
11

Metabolic syndrome is a cluster of five risk factors that dramatically raise your chance of heart disease and diabetes. It's silent, common, and reversible with lifestyle changes - not pills.

Migraine Medications: Triptans, Gepants, and Ditans Safety Compared

Keith Ashcroft
|
March 21
|
15

Triptans, gepants, and ditans treat migraines differently-and their safety profiles vary greatly. Learn which is safest for your heart, lifestyle, and daily responsibilities.

FDA MedWatch: How to Report Side Effects and Adverse Drug Reactions

Keith Ashcroft
|
March 20
|
9

Learn how to report side effects and adverse reactions to the FDA using MedWatch. This guide explains who should report, how to fill out the forms, and why your report matters for public safety.

How to Safely Manage Expired Inhalers, Eye Drops, and Topical Medications

Keith Ashcroft
|
March 13
|
10

Expired inhalers, eye drops, and topical medications lose potency and can become unsafe. Learn how to safely dispose of them and why using them past expiration can be dangerous - especially during emergencies.

IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Testing in Bioequivalence

Keith Ashcroft
|
March 7
|
10

IVIVC uses lab-based dissolution testing to predict how a drug behaves in the body, allowing regulators to waive costly human bioequivalence trials. Learn how it works, where it succeeds, and why it’s reshaping generic drug approval.

Home Hemodialysis: Schedules, Training, and Outcomes

Keith Ashcroft
|
February 28
|
13

Home hemodialysis offers greater flexibility and better health outcomes than in-center treatment, but requires intensive training, a care partner, and home setup. Learn about schedules, training timelines, and real-world outcomes.

Fertility Preservation Options Before Chemotherapy: What You Need to Know

Keith Ashcroft
|
February 20
|
9

Fertility preservation before chemotherapy offers real options to protect future parenthood. From egg freezing to sperm banking, here's what works, what doesn't, and how to act fast.

Dupuytren’s Contracture: Understanding Hand Deformity and Effective Treatment Options

Keith Ashcroft
|
February 2
|
14

Dupuytren’s contracture causes fingers to bend inward due to thickened palm tissue. Learn how it develops, who’s at risk, and what treatments actually work - from needle procedures to surgery and new therapies on the horizon.

Amblyopia: How Vision Development and Patching Therapy Restore Sight in Children

Keith Ashcroft
|
January 31
|
8

Amblyopia, or lazy eye, is the leading cause of childhood vision loss. Early detection and patching therapy can restore vision in most children-but only if treatment starts before age 7. Learn how it works, why timing matters, and what alternatives exist.